Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$125.26 - $203.83 $789,639 - $1.28 Million
-6,304 Reduced 73.77%
2,241 $455,000
Q3 2023

Nov 14, 2023

BUY
$185.0 - $326.08 $1.41 Million - $2.48 Million
7,599 Added 803.28%
8,545 $1.7 Million
Q2 2023

Aug 14, 2023

BUY
$226.52 - $324.64 $214,287 - $307,109
946 New
946 $307,000
Q4 2022

Feb 14, 2023

SELL
$164.02 - $259.76 $723,656 - $1.15 Million
-4,412 Reduced 62.18%
2,683 $675,000
Q3 2022

Nov 14, 2022

BUY
$170.68 - $226.46 $913,308 - $1.21 Million
5,351 Added 306.82%
7,095 $1.26 Million
Q2 2022

Aug 15, 2022

SELL
$147.53 - $266.6 $180,576 - $326,318
-1,224 Reduced 41.24%
1,744 $319,000
Q4 2021

Feb 14, 2022

SELL
$207.57 - $280.17 $73,272 - $98,900
-353 Reduced 10.63%
2,968 $683,000
Q3 2021

Nov 15, 2021

SELL
$170.0 - $258.58 $22,100 - $33,615
-130 Reduced 3.77%
3,321 $773,000
Q1 2021

May 14, 2021

SELL
$182.45 - $249.25 $449,556 - $614,152
-2,464 Reduced 41.66%
3,451 $714,000
Q4 2020

Feb 16, 2021

BUY
$119.35 - $200.46 $705,955 - $1.19 Million
5,915 New
5,915 $1.11 Million

Others Institutions Holding INSP

About Inspire Medical Systems, Inc.


  • Ticker INSP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,788,600
  • Market Cap $5.34B
  • Description
  • Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...
More about INSP
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.